What do the stakeholders think?
Date: November 1st, 2017
In any business, keeping your stakeholders in mind is the key to the success, and in a rapidly growing field like personalised nutrition, it can be especially difficult to keep track of stakeholder attitudes. For this reason, our partners at the University of Northern Ireland, Galway have analysed stakeholder attitudes through a series of surveys.
The surveys targeted five distinct groups of key stakeholders: SMEs, End Users, Researchers, Healthcare Professionals, and Policy Makers. The groups were asked questions regarding the appeal of personalised nutrition and the importance of personalised nutrition outcomes, as well as perceived barriers to bringing personalised nutrition products and services to market.
The overall results of the surveys revealed that general attitudes toward personalised nutrition are positive among all five stakeholder groups. For instance, the vast majority of respondents strongly agreed that personalised nutrition will benefit older adults, with the levels of agreement ranging from 82% of End Users to 96% of SMEs. These numbers fell somewhat drastically when it came to invasive procedures, such as ones that include blood tests and DNA analysis. Procedures using information about diet and exercise, however, was still considered appealing.
One extremely promising result is that all five groups agreed that personalised nutrition can be used to improve health and prevent a future illness.
As for perceived barriers to bringing personalised nutrition to market, all stakeholder groups believed that there is little to no knowledge or training in nutrition among Healthcare Professionals and a lack of trust in product manufacturers among End Users.
Overall, the surveys revealed that stakeholders tend to look at personalised nutrition in a positive light. There are, of course, barriers, but there is a general consensus among stakeholders that the field has great potential, as long as non-invasive procedures are used.
Read the full research paper here.